Early Erythropoietin Administration does not Increase the Risk of Retinopathy in Preterm Infants.

[1]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[2]  P. Hüppi,et al.  Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age. , 2014, JAMA.

[3]  Hong‐Lin Chen,et al.  Erythropoietin and retinopathy of prematurity: a meta-analysis , 2014, European Journal of Pediatrics.

[4]  A. Ohlsson,et al.  Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. , 2014, The Cochrane database of systematic reviews.

[5]  Y. Kandasamy,et al.  The effect of erythropoietin on the severity of retinopathy of prematurity , 2014, Eye.

[6]  R. Ohls,et al.  A Randomized, Masked, Placebo-Controlled Study of Darbepoetin Alfa in Preterm Infants , 2013, Pediatrics.

[7]  B. Fleck.  Management of retinopathy of prematurity , 2013, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[8]  S. Juul,et al.  Outcomes of extremely low birth weight infants given early high-dose erythropoietin , 2013, Journal of Perinatology.

[9]  A. Hakeem,et al.  Retinopathy of Prematurity: A Study of Prevalence and Risk Factors , 2012, Middle East African journal of ophthalmology.

[10]  R. Ali,et al.  Vascular Biology , Atherosclerosis , and Endothelium Biology Endogenous Erythropoietin Protects Neuroretinal Function in Ischemic Retinopathy , 2012 .

[11]  S. Rees,et al.  Erythropoietin protects the developing retina in an ovine model of endotoxin-induced retinal injury. , 2011, Investigative ophthalmology & visual science.

[12]  J. Figueras-Aloy,et al.  [Early administration of erythropoietin in the extreme premature, a risk factor for retinopathy of prematurity?]. , 2010, Anales de pediatria.

[13]  V. Paul,et al.  Retinopathy of Prematurity , 2005, The Indian Journal of Pediatrics.

[14]  J. Figueras-Aloy,et al.  [Early administration of erythropoietin in the extreme premature, a risk factor for retinopathy of prematurity?]. , 2010, Anales de pediatria.

[15]  J. Sears.  Stimulating angiogenesis to prevent ischemic retinopathy. , 2009, Ophthalmology.

[16]  T. Fujikado,et al.  Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity. , 2009, Ophthalmology.

[17]  J. Dunaief,et al.  Iron homeostasis and eye disease. , 2009, Biochimica et biophysica acta.

[18]  M. Wolf,et al.  An Approach to Using Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants , 2008, Pediatrics.

[19]  Lois E. H. Smith,et al.  A double-edged sword: erythropoietin eyed in retinopathy of prematurity. , 2008, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[20]  Lois E. H. Smith,et al.  Erythropoietin deficiency decreases vascular stability in mice. , 2008, The Journal of clinical investigation.

[21]  浦尾 紀文.  Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia , 2006 .

[22]  Noha S. Daher Msph.  Human Recombinant Erythropoietin and the Incidence of Retinopathy of Prematurity: A Multiple Regression Model , 2006 .

[23]  A. Ohlsson,et al.  Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. , 2006, The Cochrane database of systematic reviews.

[24]  S. Juul,et al.  Erythropoietin Protects Dopaminergic Neurons and Improves Neurobehavioral Outcomes in Juvenile Rats after Neonatal Hypoxia-Ischemia , 2005, Pediatric Research.

[25]  B. Arif,et al.  Recombinant human erythropoietin therapy in low‐birthweight preterm infants: A prospective controlled study , 2005, Pediatrics international : official journal of the Japan Pediatric Society.

[26]  A. Berger,et al.  Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurity , 2004, Thrombosis and Haemostasis.

[27]  W. Jelkmann,et al.  Beneficial and ominous aspects of the pleiotropic action of erythropoietin , 2004, Annals of Hematology.

[28]  K. Maiese,et al.  Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase‐mediated pathways , 2003, British journal of pharmacology.

[29]  P. Groneck,et al.  Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. , 2002, The Journal of pediatrics.

[30]  L. Wright,et al.  Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. , 2001, Pediatrics.

[31]  L. Ho,et al.  Effect of recombinant human erythropoietin on transfusion needs in preterm infants , 2001, Journal of paediatrics and child health.

[32]  C. Dani,et al.  The role of blood transfusions and iron intake on retinopathy of prematurity. , 2001, Early human development.

[33]  H. Tamai,et al.  Blood transfusion increases radical promoting non-transferrin bound iron in preterm infants , 2001, Archives of disease in childhood. Fetal and neonatal edition.

[34]  J. Widness,et al.  Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. , 2001, Pediatrics.

[35]  F. Gallini,et al.  Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity? , 2000, European Journal of Pediatrics.

[36]  R. D. Da Riol,et al.  Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants , 1998, Archives of disease in childhood. Fetal and neonatal edition.

[37]  T. Inder,et al.  High iron status in very low birth weight infants is associated with an increased risk of retinopathy of prematurity. , 1997, The Journal of pediatrics.

[38]  G. Krystal,et al.  Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions. , 1996, The Journal of pediatrics.

[39]  R. Ehrenkranz,et al.  Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. , 1995, Pediatrics.

[40]  G. Duc,et al.  The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants , 1994 .